Corcept Therapeutics Incorporated (CORT)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	482,375	401,858	365,978	353,874	306,486
Property, plant and equipment	US$ in thousands	195	633	1,002	1,675	1,050
Fixed asset turnover		2,473.72	634.85	365.25	211.27	291.89

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $482,375K ÷ $195K
= 2,473.72

Corcept Therapeutics Inc's fixed asset turnover ratio has exhibited a significant upward trend over the past five years, reflecting the company's enhanced efficiency in generating revenue from its fixed assets. The ratio increased from 291.89 in 2019 to 2,473.72 in 2023, indicating a substantial improvement in utilizing its fixed assets to generate sales. This indicates that the company is able to generate more revenue per dollar invested in fixed assets, which could suggest effective management of its asset base and operations. The consistent increase in the fixed asset turnover ratio implies that Corcept Therapeutics Inc has been successful in optimizing its asset utilization and improving operational efficiency over the years.